← 產業報告目錄
Primary Cells Market Size, Share & Trends Analysis Report By Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), By Origin (Human Primary Cells, Animal Primary Cells), By End-User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-06頁數 179報告編號 INSIGHTACE-51f0878e48
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Primary Cells Market stood at USD 1.94 Bn in 2024, and is forecasted to reach USD 5.18 Bn by 2034, recording a CAGR of 10.4% from 2025 through 2034.
Primary Cells encompasses cells isolated from a living organism as opposed to "cell lines," which have been grown for a long time and are frequently employed in various biological and medical research purpose. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is underpinned by mounting call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Primary Cells Market Snapshot
Chapter 4. Global Primary Cells Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
5.2.1. Hematopoietic,
5.2.2. Dermatocytes,
5.2.3. Hepatocytes,
5.2.4. Gastrointestinal,
5.2.5. Lung,
5.2.6. Renal,
5.2.7. Heart,
5.2.8. Musculoskeletal
Chapter 6. Market Segmentation 2: By Origin Estimates & Trend Analysis
6.1. By Origin & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Origin:
6.2.1. Human Primary Cells,
6.2.2. Animal Primary Cells
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
7.2.1. Life Science Research Companies,
7.2.2. Research Institutes,
7.2.3. Others
Chapter 8. Primary Cells Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
8.1.2. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By Origin, 2019-2031
8.1.3. North America Primary Cells Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
8.1.4. North America Primary Cells Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Primary Cells Market revenue (US$ Million) By Type, 2019-2031
8.2.2. Europe Primary Cells Market revenue (US$ Million) By Origin, 2019-2031
8.2.3. Europe Primary Cells Market revenue (US$ Million) By End User, 2019-2031
8.2.4. Europe Primary Cells Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Primary Cells Market revenue (US$ Million) By Type, 2019-2031
8.3.2. Asia Pacific Primary Cells Market revenue (US$ Million) By Origin, 2019-2031
8.3.3. Asia Pacific Primary Cells Market revenue (US$ Million) By End User, 2019-2031
8.3.4. Asia Pacific Primary Cells Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Primary Cells Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.4.2. Latin America Primary Cells Market revenue (US$ Million) By Origin, (US$ Million) 2019-2031
8.4.3. Latin America Primary Cells Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.4.4. Latin America Primary Cells Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Primary Cells Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Primary Cells Market revenue (US$ Million) By Origin, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Primary Cells Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Primary Cells Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific, Inc.
9.2.2. Merck KgAa
9.2.3. Corning Incorporated
9.2.4. Lonza Group
9.2.5. Charles River Laboratories, Inc.
9.2.6. PromoCell Gmbh
9.2.7. American Type Culture Collection (ATCC)
9.2.8. Cell Biologics, Inc.
9.2.9. Zen-Bio, Inc.
9.2.10. Stemcell Technologies, Inc.
9.2.11. AllCells
9.2.12. iXCells Biotechnologies
9.2.13. Neuromics
9.2.14. Axol Bioscience Ltd.
9.2.15. StemExpress
9.2.16. Bioivt
9.2.17. ScienCell Research Laboratories, Inc.
9.2.18. AMSBIO
9.2.19. ProMab Biotechnologies, Inc.
9.2.20. Creative Bioarray
9.2.21. Bps Bioscience, Inc.
9.2.22. Epithelix
9.2.23. Reachbio Research Labs
9.2.24. AcceGen
9.2.25. Kosheeka
9.2.26. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們